Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03775954 · ClinicalTrials.gov registry record
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
A clinical trial of Congenital Heart Disease and High Risk Pregnancy, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- 30
- Enrollment target
- 2
- Study locations
NCT03775954 is a study of Congenital Heart Disease and High Risk Pregnancy that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 30 participants, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03775954, a study of Congenital Heart Disease and High Risk Pregnancy, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetocardiography (fMCG) used thus far to successfully evaluate fetal arrhythmias, in order to discover potential hidden electrophysiologic abnormalities that could lead to fetal demise in five high-risk pregnancy conditions associated with fetal demise.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Fetal Magnetocardiogram and Neonatal Electrocardiogram
- GENETIC Substudy only: Maternal/Infant Pharmacogenomic assessment postnatally
Study Locations (2)
Wisconsin
- University of Wisconsin - Madison - Madison
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2028-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03775954
The ClinicalTrials.gov registry entry for NCT03775954 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (94% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 2 interventions - of which Fetal Magnetocardiogram and Neonatal Electrocardiogram is the first listed.
NCT03775954 reports 2 study locations spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03775954 about?
NCT03775954 is a clinical study titled "Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise". Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetocardiography (fMCG) u...
What is the current status of trial NCT03775954?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2018-07-01. Estimated completion is 2028-11-30.
What conditions does trial NCT03775954 study?
This clinical trial studies the following conditions: Congenital Heart Disease, High Risk Pregnancy, Long QT Syndrome, Gastroschisis, Stillbirth.
What interventions are being tested in trial NCT03775954?
The interventions under investigation include: Fetal Magnetocardiogram and Neonatal Electrocardiogram (DIAGNOSTIC_TEST), Substudy only: Maternal/Infant Pharmacogenomic assessment postnatally (GENETIC).
Who is sponsoring clinical trial NCT03775954?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03775954 being conducted?
This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
PDA for Kidneys Study
RECRUITING
-
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.